AGL Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017

◆英語タイトル:AGL Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017
◆商品コード:DATA904C3178
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:グローバル
◆産業分野:石油・ガス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

AGL Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
Summary

AGL Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational metrics, analysis and provides a strategic insight into the company. The report provides an annual and quarterly overview of oil and gas reserves and production, changes in reserves, costs incurred and results of oil and gas operations, acreage and well details, share price performance and key valuation metrics.

Scope

The report provides in-depth analysis and insights into companies’ capital spending, revenues, oil and gas reserves, production, and performance measures. Its scope includes the following –
- The report provides detailed and unique insight information on the key operational metrics. It gives a comprehensive overview of oil and gas production and reserves, costs incurred and results of oil and gas operations, acreage and well details and other performance metrics.
- Provides details with respect to the company’s oil and gas reserves and production information by country. It further consists of in-depth information on the company’s expenditures in relation to the acquisition, exploration and development activities; developed and undeveloped acreage position; key costs and revenue information; and performance metrics of the company as disclosed in its annual reports and regulatory filings.
- Provides a comprehensive overview of the company’s share price performance and key valuation metrics such as market capitalization, enterprise value, EV/Production ($boe/d) and EV/Proved Reserve ($/boe)
- Provides information on key operational and financial metrics on an annual and quarterly basis. The annual information provided is for a five-year period and the quarterly information is for the last five quarters.

*Note:

1. The scope mentioned above is generic and may not apply to all the companies. The report is based on the information disclosed by the companies in their annual and quarterly reports, regulatory filings and other company documents and sources.
2. Quarterly information is provided only for the companies that are December ending and files quarter reports and documents.
3. There can be cases where countries/regions data column/Charts will be blank. This can be due to the fact that the company might have discontinued the reporting of those countries/regions. Information that is not disclosed by the company may not be available in the report.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to –
- Be up-to-date with the latest information and in-depth analysis of the operational metrics of the company.
- Identify M&A targets from up-to-date information and in-depth analysis on financial and operational metrics of your competitors.
- Rank your performance against other companies in the exploration and production (E&P) sector using operational and financial benchmarking metrics.
- Formulate your strategies based on in-depth analysis of your competitors’ financial and operational data.
- Exploit the strengths and weakness of your closest competitors by comparing and analyzing their financial and operational metrics.
- Establish relative performance among the industry’s players based on key operational and financial measures.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Company Snapshot 5
Key Information 5
Company Overview 5
AGL Energy Ltd, Valuation and Financial Data, 2013-2017 6
AGL Energy Ltd, Share Price Performance, 2013-2017 6
Share Price Performance, 2013-2017 6
Key Valuation Metrics, 2013-2017 7
AGL Energy Ltd, Production and Reserves Trends 8
Total Oil and Gas, Reserves and Production 8
Total Crude Oil and Natural Gas Production and Reserves Trend, 2013-2017 8
Total Crude Oil & Natural Gas Production and Reserves By Country/Region, 2013-2017 9
Total Crude Oil and Natural Gas Reserve Changes, 2013-2017 10
Natural Gas Production and Reserve 11
Natural Gas Production and Reserve Trend, 2013-2017 11
Natural Gas Production and Reserves, By Country/Region, 2013-2017 12
Natural Gas Reserve Changes, 2013-2017 13
Total Crude Oil and Natural Gas Reserves Life Index 14
Total Crude Oil and Natural Gas Reserves Life Index, 2013-2017 14
AGL Energy Ltd, E&P Costs Trends 15
Allocation of the Upstream Capital Expenditure 15
Upstream Capital Expenditure, 2013-2017 15
Exploration and Development Costs, By Country/Region, 2013-2017 16
AGL Energy Ltd, Results of Oil & Gas Operations Trend 18
Oil and Gas Revenue and Expenses 18
Oil and Gas Revenue and Expenses, 2013-2017 18
Oil and Gas Revenue and Expenses, By Country/Region, 2013-2017 19
Oil and Gas Revenue and Expenses, Per boe 20
Oil and Gas Revenue and Expenses, By boe, 2013-2017 20
Oil and Gas Revenue and Expenses Per boe, By Country/Region, 2013-2017 21
Recent Developments 23
AGL Energy Ltd – Recent Developments 23
Aug 09, 2018: AGL Energy reports rise in profits following power price surge 23
Jun 12, 2018: APA To Develop Crib Point Pakenham Pipeline For AGL’s LNG Import Facility 23
Jun 12, 2018: AGL Signs Two Agreements For Gas Import Jetty As Consultation Continues 24
Jun 11, 2018: ABB to install multipurpose microgrid in Australia 25
Jun 08, 2018: AGL cuts electricity prices across NSW, SA and Queensland 26
May 21, 2018: AGL launches new service to help Victorians with their energy decisions 27
May 02, 2018: Cooper Energy Announces Sole-3 Underway 28
Apr 12, 2018: AGL Part Of World-First Hydrogen Energy Supply Chain Project 28
Apr 04, 2018: Alinta Approach For Liddell Power Station 29
Mar 13, 2018: AGL upgrades VPP with latest technology from Tesla, SolarEdge and LG Chem 29
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 32
Data Information Sources 32
Company Source 32
SEC/Other Regulatory Filings 32
Other Sources 32
Expert Panel Validation 32
Data Definition 32
Oil and Gas Reserves 32
Units of Measure 33
About GlobalData 34
Disclosure 34
Disclaimer 34

List of Tables
Table 1: AGL Energy Ltd, Key Facts 5
Table 2: AGL Energy Ltd, Share Price Performance, 2013-2017 6
Table 3: AGL Energy Ltd, Key Valuation Metrics, 2013-2017 7
Table 4: AGL Energy Ltd, Total Crude Oil and Natural Gas, Production and Reserves, mmboe, 2013-2017 8
Table 5: AGL Energy Ltd, Total Crude Oil & Natural Gas Production and Reserves, By Country/Region, mmboe, 2013-2017 9
Table 6: AGL Energy Ltd, Total Crude Oil and Natural Gas Reserve Changes, mmboe, 2013-2017 10
Table 7: AGL Energy Ltd, Natural Gas Production and Reserves Metrics, bcf, 2013-2017 11
Table 8: AGL Energy Ltd, Natural Gas Production and Reserves, By Country/Region, bcf, 2013-2017 12
Table 9: AGL Energy Ltd, Natural Gas Reserve Changes, bcf, 2013-2017 13
Table 10: AGL Energy Ltd, Oil and Gas Reserves Life Index, Years, 2013-2017 14
Table 12: AGL Energy Ltd, Upstream Capital Expenditure, US$ mil, 2013-2017 15
Table 13: AGL Energy Ltd, Exploration and Development Costs, By Country/Region, US$ mil, 2013-2017 17
Table 14: AGL Energy Ltd, Revenue and Expenses, US$ mil, 2013-2017 18
Table 15: AGL Energy Ltd, Revenue and Expenses, By Country/Region, US$ mil, 2013-2017 19
Table 16: AGL Energy Ltd, Oil and Gas Revenue and Expenses, US$/boe, 2013-2017 20
Table 17: AGL Energy Ltd, Oil and Gas Revenue and Expenses, US$/boe, By Country/Region, 2013-2017 22

List of Figures
Figure 1: AGL Energy Ltd, Share Price Performance, AUD/Share, 2013-2017 6
Figure 2: AGL Energy Ltd, Total Crude Oil and Natural Gas, Production and Reserves, mmboe, 2013-2017 8
Figure 5: AGL Energy Ltd, Natural Gas Production and Reserves Metrics, bcf, 2013-2017 11
Figure 7: AGL Energy Ltd, Gas Production, By Country/Region, bcf, 2013-2017 12
Figure 8: AGL Energy Ltd, Oil and Gas Reserves Life Index, Years, 2013-2017 14
Figure 9: AGL Energy Ltd, Upstream Capital Expenditure, US$ mil, 2013-2017 15
Figure 10: AGL Energy Ltd, Development Costs, By Country/Region, US$ mil, 2013-2017 16
Figure 11: AGL Energy Ltd, Exploration Costs, By Country/Region, US$ mil, 2013-2017 16
Figure 12: AGL Energy Ltd, Revenue and Expenses, US$ mil, 2013-2017 18
Figure 14: AGL Energy Ltd, Oil & Gas Revenue, By Country/Region, US$ mil, 2013-2017 19
Figure 15: AGL Energy Ltd, Oil and Gas Revenue and Expenses, US$/boe, 2013-2017 20
Figure 16: AGL Energy Ltd, Oil & Gas Revenue per boe, By Country/Region, US$/boe, 2013-2017 21
Figure 18: AGL Energy Ltd, Total Revenue per boe, By Country/Region, US$/boe, 2013-2017 22

★海外企業調査レポート[AGL Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Apotex Inc:企業の戦略的SWOT分析
    Apotex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • TiGenix NV (TIG):企業の財務・戦略的SWOT分析
    Summary TiGenix NV (TiGenix), a subsidiary of Takeda Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and commercializes novel therapeutic products. The company exploits the anti-inflammatory properties of stem cells to develop novel therapies. It offers products such as AlloCSC-0 …
  • Dai Nippon Printing Co., Ltd.:企業の戦略・SWOT・財務分析
    Dai Nippon Printing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dai Nippon Printing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • PetroChina Co Ltd (857):企業の財務・戦略的SWOT分析
    PetroChina Co Ltd (857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Citrix Systems Inc (CTXS):企業の財務・戦略的SWOT分析
    Citrix Systems Inc (CTXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Vp Plc (VP.):企業の財務・戦略的SWOT分析
    Summary Vp Plc (Vp) is a provider of equipment rental services. The company offers material handling equipment rental for housing, general construction and other industries; equipment for shoring and piling, pipe stoppers, pumps, temporary bridges and excavation support equipment for water, gas, civ …
  • Regulus Therapeutics Inc (RGLS):企業の財務・戦略的SWOT分析
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target micr …
  • GFH Financial Group BSC (GFH):企業の財務・戦略的SWOT分析
    GFH Financial Group BSC (GFH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Chesapeake Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Chesapeake Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Chesapeake Energy Corp (Chesapeake) is an upstream oil and gas company in the US. The company explores for, develops and produces oil and gas from its assets. It has liquid operations in Eagle …
  • Dignitana AB (DIGN):医療機器:M&Aディール及び事業提携情報
    Summary Dignitana AB (Dignitana), a subsidiary of Eurosund AB, designs, develops, manufactures and markets medical cooling systems.. The company’s DigniCap Scalp Cooling System helps reduce or eliminate hair loss in patients undergoing chemotherapy. The DigniCap system comprises a silicone cap and a …
  • Sun Hung Kai Properties Limited:戦略・SWOT・企業財務分析
    Sun Hung Kai Properties Limited - Strategy, SWOT and Corporate Finance Report Summary Sun Hung Kai Properties Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • UCB S.A.:企業のM&A・事業提携・投資動向
    UCB S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's UCB S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Aptevo Therapeutics Inc (APVO):製薬・医療:M&Aディール及び事業提携情報
    Summary Aptevo Therapeutics Inc (Aptevo), a subsidiary of Emergent Biosolutions Inc, is a biotechnology company that develops and commercializes oncology and hematology therapeutics. The company’s only marketed product Ixinity that is indicated to replace the missing clotting factor IX in adults and …
  • A-Sonic Aerospace Limited:企業の戦略・SWOT・財務分析
    A-Sonic Aerospace Limited - Strategy, SWOT and Corporate Finance Report Summary A-Sonic Aerospace Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • CITGO Petroleum Corporation:企業の戦略・SWOT・財務情報
    CITGO Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary CITGO Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Nevro Corp (NVRO)-医療機器分野:企業M&A・提携分析
    Summary Nevro Corp (Nevro) is a medical device company that offers therapeutic equipment. The company provides pain relief therapies for low back pain and other types of chronic pain. Its services include SCS therapy and clinical trials. Nevro’s SCS therapy is a low-frequency spinal cord stimulation …
  • Hawaiian Holdings, Inc.:企業の戦略・SWOT・財務情報
    Hawaiian Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hawaiian Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Tocardo International BV:電力:M&Aディール及び事業提携情報
    Summary Tocardo International BV (Torcado), a subsidiary of Tribute Resources Inc, is an energy equipment provider that manufactures and markets offshore turbines. The company offers wind turbines, sea defences, commercial demonstrator and others. It also offers river and tidal turbines. Torcado’s p …
  • Intel Corporation:企業のM&A・事業提携・投資動向
    Intel Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Intel Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Fujirebio Diagnostics Inc:企業の製品パイプライン分析2018
    Summary Fujirebio Diagnostics Inc (FDI), a subsidiary of Fujirebio Inc is a healthcare diagnostic company that manufactures, markets and develops biomarker assays and in-vitro diagnostic products. The company’s products include OEM custom solutions, manual kits, serum products, multi-constituent con …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆